Skip to main content
. 2017 Aug 7;13(1):44–53. doi: 10.1016/j.ajps.2017.07.003

Fig. 4.

Fig. 4

The in vivo tracking of the intravenous injected nanoemulsions at the dose of 5 µmol phospholipid/kg (1%GE, 3%GE, 9%GE and 9%PE) in rats, n = 3. (A) The in vivo imaging performed at 10, 30, 240 and 480 min after the injection of the 1%GE, 3%GE, 9%GE and 9%PE respectively. (B) Time profiles of region-of-interest (ROI) analyses. Each value represents the mean ± SD of three animals. ***P <0.005.